Maryland Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $23.3M | Sell |
281,700
-2,807
| -1% | -$232K | 1.94% | 11 |
|
2022
Q2 | $27.1M | Sell |
284,507
-34,276
| -11% | -$3.26M | 2.13% | 9 |
|
2022
Q1 | $37.5M | Sell |
318,783
-407
| -0.1% | -$47.9K | 2.35% | 8 |
|
2021
Q4 | $41.4M | Buy |
319,190
+13,542
| +4% | +$1.75M | 2.24% | 14 |
|
2021
Q3 | $34.6M | Buy |
+305,648
| New | +$34.6M | 2.07% | 17 |
|
2021
Q2 | – | Sell |
-303,434
| Closed | -$25.4M | – | 258 |
|
2021
Q1 | $25.4M | Buy |
+303,434
| New | +$25.4M | 1.7% | 20 |
|
2020
Q4 | – | Sell |
-272,117
| Closed | -$21.7M | – | 225 |
|
2020
Q3 | $21.7M | Buy |
+272,117
| New | +$21.7M | 1.78% | 20 |
|
2019
Q4 | – | Sell |
-196,557
| Closed | -$14.4M | – | 183 |
|
2019
Q3 | $14.4M | Buy |
196,557
+4,962
| +3% | +$364K | 1.65% | 22 |
|
2019
Q2 | $11.8M | Buy |
191,595
+11,400
| +6% | +$702K | 1.4% | 24 |
|
2019
Q1 | $11.5M | Buy |
180,195
+133,179
| +283% | +$8.49M | 1.42% | 24 |
|
2018
Q4 | $2.4M | Buy |
+47,016
| New | +$2.4M | 0.35% | 63 |
|
2017
Q3 | – | Sell |
-9,000
| Closed | -$355K | – | 160 |
|
2017
Q2 | $355K | Hold |
9,000
| – | – | 0.05% | 138 |
|
2017
Q1 | $282K | Hold |
9,000
| – | – | 0.04% | 144 |
|
2016
Q4 | $281K | Hold |
9,000
| – | – | 0.04% | 140 |
|
2016
Q3 | $362K | Hold |
9,000
| – | – | 0.05% | 123 |
|
2016
Q2 | $299K | Hold |
9,000
| – | – | 0.05% | 122 |
|
2016
Q1 | $265K | Hold |
9,000
| – | – | 0.04% | 131 |
|
2015
Q4 | $237K | Hold |
9,000
| – | – | 0.03% | 140 |
|
2015
Q3 | $213K | Hold |
9,000
| – | – | 0.04% | 152 |
|
2015
Q2 | $214K | Hold |
9,000
| – | – | 0.03% | 167 |
|
2015
Q1 | $214K | Buy |
+9,000
| New | +$214K | 0.03% | 169 |
|